Delivery Order SPE2DB22D3501-SPE2DB23FWU59
Award Date 8/9/23
Potential Completion Date 8/10/23
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,072.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award was issued on September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $5,800.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on October 22, 2025, with completion targeted for October 23, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation....
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on July 14, 2025, with performance completion by July 15, 2025. This non-set-aside, firm fixed price contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger vehicle supporting the federal medical supply chain. This...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,990.37 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/ml vials. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply transaction. The award represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,752.22 on May 20, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price, competitively awarded contract (no set-aside used) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this delivery order from its corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $2,752.22 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This is a firm fixed price contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the...
- The Defense Logistics Agency awarded a $2,072.25 delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/ml vials, with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing for pharmaceutical supply fulfillment. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $2,752.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,336.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PEGASYS 180 MCG/ML vials to be delivered by August 8, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will perform the order from its location in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring medical supplies to support military treatment...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a firm fixed price of $2,752.23 and a performance period ending on June 9, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...